| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/23/1994 | WO1994013801A1 Mammalian receptors for interleukin-10 (il-10) |
| 06/23/1994 | WO1994013800A2 Mk protein preparation and use in cell culture |
| 06/23/1994 | WO1994013799A1 Stably transfected cell lines expressing gaba-a receptors |
| 06/23/1994 | WO1994013798A1 Agents for the prevention and treatment of human alzheimer's disease |
| 06/23/1994 | WO1994013795A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 06/23/1994 | WO1994013794A1 Human thrombospondin-4 |
| 06/23/1994 | WO1994013791A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 06/23/1994 | WO1994013787A1 Method for enhancing the differentiation of plant cells in culture |
| 06/23/1994 | WO1994013785A2 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 06/23/1994 | WO1994013702A1 Composition containing hematopoiesis inhibitor |
| 06/23/1994 | WO1994013701A2 Delta-like gene expressed in neuroendocrine tumors |
| 06/23/1994 | WO1994013700A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | WO1994013699A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | WO1994013697A1 Treatment of septic shock with conjugated biologically active peptides |
| 06/23/1994 | WO1994013696A1 Spiro piperidines and homologs which promote release of growth hormone |
| 06/23/1994 | WO1994013692A1 Polypeptides useful for treating inflammatory disorders |
| 06/23/1994 | WO1994013684A1 Novel substance dolastatin c and pharmaceutical use thereof |
| 06/23/1994 | WO1994013323A1 Method of inhibiting the clearance of liposomes from the circulation |
| 06/23/1994 | WO1994013321A1 Suppression of myeloid cells |
| 06/23/1994 | WO1994013320A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease |
| 06/23/1994 | WO1994013319A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 06/23/1994 | WO1994013316A1 Potent and specific chemically-conjugated immunotoxins |
| 06/23/1994 | WO1994013315A1 A novel eukaryotic transcription protein: host cell factor |
| 06/23/1994 | WO1994013312A1 Mucosal vascular addressin, dna and expression |
| 06/23/1994 | WO1994013310A1 A bone sialoprotein binding protein as well as its preparation |
| 06/23/1994 | WO1994013307A1 Platelet activation and function |
| 06/23/1994 | WO1994013273A1 Sequences useful for obtaining high level, copy number-dependent, essentially position-independent gene expression in cellular and transgenic systems |
| 06/23/1994 | WO1994013264A1 Clostridial toxin disease therapy |
| 06/23/1994 | WO1994008023A3 Biotechnological method of producing biotin |
| 06/23/1994 | CA2151927A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 06/23/1994 | CA2151831A1 A disease resistance gene from maize as a selectable marker and gene identification probe |
| 06/23/1994 | CA2151587A1 Process for promoting the differenciation of plant cells during culture |
| 06/23/1994 | CA2151496A1 Nucleotide sequence for treating cancer and infection |
| 06/23/1994 | CA2151455A1 Delta-like gene expressed in neuroendocrine tumors |
| 06/23/1994 | CA2151387A1 Suppression of myeloid cells |
| 06/23/1994 | CA2151267A1 Developmental regulation in anther tissue of plants |
| 06/23/1994 | CA2151257A1 Dna encoding chitin deacetylase |
| 06/23/1994 | CA2151128A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | CA2151126A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | CA2151046A1 Treatment of septic shock with conjugated biologically active peptides |
| 06/23/1994 | CA2150935A1 Clostridial toxin disease therapy |
| 06/23/1994 | CA2150909A1 Clotting inhibitor made from protostomia saliva |
| 06/23/1994 | CA2150807A1 Dna sequence encoding the cpg-1 neutral polypeptide and the polypeptide encoded thereby |
| 06/23/1994 | CA2150249A1 Lymphotoxin-.beta., lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/23/1994 | CA2148132A1 Immunoassay for the measurement of collagen cleavage in cartilage |
| 06/23/1994 | CA2129436A1 Hematopoietic inhibiting factor containing compositions |
| 06/23/1994 | CA2112046A1 Antibodies, polypeptides, production and use thereof |
| 06/23/1994 | CA2112038A1 Inhibitors of hiv protease useful for the treatment of aids |
| 06/23/1994 | CA2112018A1 Porcine grf receptor |
| 06/23/1994 | CA2110852A1 Monoclonal antibodies that define a unique antigen of human b cell receptor complex and methods of using same for diagnosis and treatment |
| 06/22/1994 | EP0603128A1 Process for the production of polypeptides |
| 06/22/1994 | EP0603031A2 Antiviral antibiotic BU-4724V and preparation thereof |
| 06/22/1994 | EP0603030A2 Antiviral antibiotic BU-4628V and preparation thereof |
| 06/22/1994 | EP0602899A2 Modified proteins containing controllable intervening sequences and methods of their production |
| 06/22/1994 | EP0602761A1 Prevention and treatment of retroviral disease |
| 06/22/1994 | EP0602688A1 Methionine free G-CSf from prokaryotes |
| 06/22/1994 | EP0602687A1 Modified VP1/P2A regions of rhinovirus systems |
| 06/22/1994 | EP0602686A2 Lectin concentrates of mistletoe extracts and corresponding standardized, stabilized mistletoe lectin preparations, process for their production as well as medicines containing them and their use |
| 06/22/1994 | EP0602601A2 Stable antibody solution and stabilization of antibody |
| 06/22/1994 | EP0602297A1 Fish collection and elastin solutions |
| 06/22/1994 | EP0602194A1 Peptide inhibitors of inflammation mediated by selectins |
| 06/22/1994 | EP0602193A1 Enhanced expression in plants |
| 06/22/1994 | EP0602189A1 Nucleic sequence of the gene associated with x-linked kallmann syndrome, corresponding peptide sequences, diagnostic applications |
| 06/22/1994 | EP0602178A1 T cell receptor-based therapy for rheumatoid arthritis |
| 06/22/1994 | EP0602173A1 Topical fibrinogen complex |
| 06/22/1994 | EP0602144A1 Dna sequences encoding gelonin polypeptide |
| 06/22/1994 | EP0602127A1 Methods and compositions for modulating g protein action |
| 06/22/1994 | EP0602126A1 Immunoglobulin variants for specific fc epsilon receptors |
| 06/22/1994 | EP0602113A1 Callus-specific promoters |
| 06/22/1994 | EP0602098A1 Biocidal proteins |
| 06/22/1994 | EP0602079A1 POLYPEPTIDES CAPABLE OF $i(IN VIVO) INDUCTION OF ANTIBODIES THEMSELVES CAPABLE OF INHIBITING THE INVASION OF RED BLOOD CORPUSCLES BY MEROZOITES OF $i(P.FALCIPARUM), RELATED PRODUCTS AND THEIR USE IN PRODUCING VACCINE COMPOSITIONS |
| 06/22/1994 | EP0602064A1 Novel microorganism and insecticide |
| 06/22/1994 | EP0602046A1 Detection of feline immunodeficiency viruses |
| 06/22/1994 | EP0602044A1 A cDNA CLONE ENCODING A HUMAN NOREPINEPRHINE TRANSPORTER |
| 06/22/1994 | EP0602032A1 Method of preferential labelling of a phycobiliprotein with a second dye to enable multiple color assay |
| 06/22/1994 | EP0547064B1 Protease resistant pdgf and methods of use |
| 06/22/1994 | EP0545951B1 Hrsv vaccine |
| 06/22/1994 | EP0497757B1 E. coli secretory strains |
| 06/22/1994 | EP0486525B1 Stabilized protein or peptide conjugates |
| 06/22/1994 | EP0470136B1 Therapeutic agent |
| 06/22/1994 | EP0418219B1 cDNAs ENCODING SOMATOTROPIN, EXPRESSION VECTORS AND HOSTS |
| 06/22/1994 | EP0413024B1 Protein having activity of inhibiting inflammation-inducing phospholipase a2 |
| 06/22/1994 | EP0409895B1 A pasteurella vaccine |
| 06/22/1994 | EP0403568B1 Synthetic peptide antigens for the detection of htlv-1 infection |
| 06/22/1994 | EP0302887B1 Bacterial antigens, antibodies, vaccines, and methods of manufacture |
| 06/22/1994 | EP0273040B1 Biological containment |
| 06/22/1994 | EP0177568B1 Recombinant dna molecules |
| 06/22/1994 | EP0176588B1 Platelet related growth regulator |
| 06/22/1994 | CN1088217A Vaccines |
| 06/22/1994 | CN1088216A Modified platelet factor-4 |
| 06/22/1994 | CN1088210A Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 06/21/1994 | US5322936 Nucleic acids encoding trypanosoma cruzi heparin-binding protein |
| 06/21/1994 | US5322933 Crystal structure of TGF-β-2 |
| 06/21/1994 | US5322932 Genetically engineered nematocide |
| 06/21/1994 | US5322931 Reacting in polar solvent in presence of a dehydrating agent and activating agent |
| 06/21/1994 | US5322930 Fusion protein containing carrier protein with peptide fused to cleavage site; high isoelectric point facilitates separation |
| 06/21/1994 | US5322928 Diapause hormone isolated from silkworm exhibiting improved diapause activity |
| 06/21/1994 | US5322926 Thrombin inhibitors |
| 06/21/1994 | US5322839 Protein fraction for cosmetic and dermatology care of the skin |
| 06/21/1994 | US5322838 Use of INHIB (the C3 β-chain) in the detection and inhibition of inflammation |